Lv11
30 积分 2024-07-11 加入
Structural and Physicochemical Features of Oral PROTACs
2天前
已完结
Discovery of a Series of Orally Bioavailable Androgen Receptor Degraders for the Treatment of Prostate Cancer
2天前
已完结
Therapeutic Strategies to Target the Androgen Receptor
2天前
已完结
Discovery of ZLC491 as a Potent, Selective, and Orally Bioavailable CDK12/13 PROTAC Degrader
4天前
已完结
Three-dimensional saturated C(sp3)-rich bioisosteres for benzene
1个月前
已完结
Pan-KRAS inhibitor disables oncogenic signalling and tumour growth
2个月前
已完结
Catalytic Glycosylation for Minimally Protected Donors and Acceptors
2个月前
已完结
BRD4 degrader ARV-825 produces long-lasting loss of BRD4 protein and exhibits potent efficacy against cholangiocarcinoma cells
3个月前
已完结
A beginner’s guide to current synthetic linker strategies towards VHL-recruiting PROTACs
3个月前
已完结
皖公网安备34019202002308
